@article{Sheikh_A-2021_49552,
title = {BNT162b2 and ChAdOx1 nCoV-19 Vaccine Effectiveness against Death from the Delta Variant},
author = {Sheikh, A. and Robertson, C. and Taylor, B.},
month = {oct},
year = {2021},
abstract = {We recently reported vaccine effectiveness for the BNT162b2 vaccine (Pfizer–BioNTech) and the ChAdOx1 nCoV-19 vaccine (AstraZeneca) against infection and hospitalization caused by the B.1.617.2 (delta) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Scotland.At that time, the number of deaths was too small to allow estimation of vaccine effectiveness against death from infection with the delta variant.},
journal = {New England Journal of Medicine},
publisher = {Massachusetts Medical Society},
url = {https://doi.org/10.1056/NEJMc2113864},
}
